AwThis week, North American mining analyst Jay Currie of MotherlodeTV.net published a new article on Tocvan Ventures Corp. (CSE: TOC; WKN: A2PE64). In his report he explains the great potential of the El Picacho gold project takeover and the positive effects on the previous and future share price development. His verdict couldn't be better: He is thrilled that Tocvan is now promoting a second gold project in addition to his main Pilar project, which can significantly increase the company's value. Virtually every successful gold company has multiple projects running at the same time in order to delight shareholders with increased news flow and successful project progress. Advertisement Real Estate Financing - We Compare, You Save You want to build a house, buy an apartment or invest in a property? With refinancing, you can put your desire for property into practice right away: In addition to your equity, you receive a loan that you repay the lender plus interest. Find out more powered by finative His last sentence hits the nail on the head: If gold continues to rise and Tocvan continues to publish good drilling results, the current share price will look "very, very cheap" in retrospect. Tocvan only has 28.4 million shares in the market, so even at $ 3 per share, the company's market value of $ 85 million would still be cheap, considering that Pilar is being developed into a highly profitable open pit mine. Jay Currie also mentioned in his article that if Tocvan took out a $ 5 million financing at the current price of $ 1.61, there would be only 3.1 million new shares to be issued, bringing the total to 28.4 million would increase to around 31.5 million shares. And if such a large amount of funding is raised by a strategic investor / company, then it can be assumed that the new shares are in solid, long-term-oriented hands and that it will have a very positive effect on the share price, as it is with Minera Alamos Inc. and the participation by Osisko Gold Royalties Ltd. it was also the case (the stock quintupled in less than 12 months). We should be thrilled! At least Jay Currie gives Tocvan a very good report card.